2018 International Congress Archives - Page 2 of 177

1:45pm-3:15pm: A case report of an Egyptian family with a rare condition of choreoacanthocytosis and amyotrophy

A. Dahshan, S. Ahmed, A. Hasan, A.S. Othman, D. Mekkawy, O. Yakoub, D. Abdulatif, Y. Gamil (Cairo, Egypt)

Tics/Stereotypies · Hall 3FG

1:45pm-3:15pm: A clinical tool to ensure delivery of modern personalised medicine for Parkinson’s disease: first description of a personalised medicine checklist

N. Titova, K. Ray Chaudhuri (Moscow, Russian Federation)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: A Computer-Aided Prescription Model for Parkinson’s Disease could predict the suitable drugs for Parkinson’s disease (PD) patients

Y. Pan, L. Zhang (Nanjing, China)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: A controlled trial of ParkinSong singing groups to improve communication and wellbeing in Parkinson’s disease

J. Tamplin, A. Vogel, C. Marigliani, F. Baker, M. Morris (Southbank, Australia)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: A Double-Blind, Randomized, Placebo-Controlled, Cross-Over Phase IIa Trial to Evaluate the Efficacy of CVXL-0107 on Parkinson-Related Symptoms and Levodopa-Induced Dyskinesia in Advanced Parkinson’s Disease

JC. Corvol, F. Durif, W. Meissner, JP. Azulay, R. Haddad, D. Bricout, X. Wang-Zhang, L. Benel, O. Rascol, Fr. NS-Park/F-CRIN Network (Paris, France)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: A first-in-human clinical study to test the safety and preliminary efficacy of CDNF in Parkinson’s disease

H. Huttunen, S. Booms, J. Koskinen, M. Saarma (Espoo, Finland)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: A framework to facilitate competence in practice for Parkinson’s Disease Nurse Specialists in the United Kingdom

H. Martin, J. Price, L. Ebenezer (Coventry, United Kingdom)

Education in Movement Disorders · Hall 3FG

1:45pm-3:15pm: A German-Austrian multicenter, non-interventional, prospective study for the treatment with abobotulinumtoxinA injections in naïve and previously treated patients suffering from cervical dystonia

W. Jost, A. Schramm, M. Müngersdorf, A. Stenner, P. Schwingenschuh, P. Maisonobe, M. Koch, B. Haslinger (Wolfach, Germany)

Clinical Trials and Therapy in Movement Disorders · Hall 3FG

1:45pm-3:15pm: A multimodal motor skill balance training with rhythmical cues to improve and maintain balance control in Parkinson’s disease

T. Capato, J. Nonnekes, J. Tornai, I. Kayo, J. IntHout, E. Barbosa, N. de Vries, M. Piemonte, B. Bloem (Sāo Paulo, Brazil)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: A new distinct spastic ataxia with hypomyelination: Clinical, neuroimaging and molecular expression of NKX6-2 mutations

V. Chelban, N. Kaya, M. Alsagob, S. Efthymiou, J. Vandrovcova, D. Lynch, K. Kloth, A. Chirita-Emandi, F. Alkuraya, N. Wood, H. Houlden (London, United Kingdom)

Genetics (Non-PD) · Hall 3FG